Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 650 of 3173 entries
View as:

BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

Phase: N/A Priority: Normal
NCT ID: NCT04478357 Org: User:
Start: 11/12/19 End: 11/12/20 Due: 11/12/21

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Phase: N/A Priority: Normal
NCT ID: NCT05228470 Org: User:
Start: 12/21/21 End: 08/31/25 Due: 08/31/26

Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

Phase: N/A Priority: Normal
NCT ID: NCT00743652 Org: User:
Start: 01/31/09 End: 09/30/10 Due: 09/30/11

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Phase: N/A Priority: Normal
NCT ID: NCT05568719 Org: User:
Start: 12/28/22 End: 02/25/40 Due: 02/25/41

Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults

Phase: N/A Priority: Normal
NCT ID: NCT00331175 Org: User:
Start: 07/31/06 End: 12/31/06 Due: 12/31/07

Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02202837 Org: User:
Start: 08/12/14 End: 04/24/17 Due: 04/24/18

Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)

Phase: N/A Priority: Normal
NCT ID: NCT01224626 Org: User:
Start: 05/31/06 End: 04/30/11 Due: 04/30/12

A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT00969813 Org: User:
Start: 11/30/09 End: 01/31/10 Due: 01/31/11

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04124653 Org: User:
Start: 10/17/19 End: 07/26/21 Due: 07/26/22

Thorough QT Study of Nelfinavir

Phase: N/A Priority: Normal
NCT ID: NCT00312182 Org: User:
Start: 03/31/06 End: 06/30/06 Due: 06/30/07

A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT00599638 Org: User:
Start: 04/09/08 End: 12/23/08 Due: 12/23/09

Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin

Phase: N/A Priority: Normal
NCT ID: NCT00932165 Org: User:
Start: 12/31/04 End: 11/30/08 Due: 11/30/09

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002140 Org: User:
Start: - End: - Due: -

Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)

Phase: N/A Priority: Normal
NCT ID: NCT01702506 Org: User:
Start: 10/31/12 End: 01/31/13 Due: 01/31/14

Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00447005 Org: User:
Start: 02/28/07 End: 08/31/09 Due: 08/31/10

A Study Comparing Amounts of Tafamidis (PF-06291826) in the Blood Without Food in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02746926 Org: User:
Start: 04/29/16 End: 07/15/16 Due: 07/15/17

Open Label Extension In Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00830180 Org: User:
Start: 10/29/09 End: 02/14/13 Due: 02/14/14

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04016077 Org: User:
Start: 07/19/19 End: 03/05/20 Due: 03/05/21

Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC

Phase: N/A Priority: Normal
NCT ID: NCT04375150 Org: User:
Start: 12/02/19 End: 10/28/22 Due: 10/28/23

European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies

Phase: N/A Priority: Normal
NCT ID: NCT05043506 Org: User:
Start: 02/08/22 End: 11/02/23 Due: 11/02/24

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

Phase: N/A Priority: Normal
NCT ID: NCT00036270 Org: User:
Start: 08/31/01 End: 02/28/11 Due: 02/28/12

A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

Phase: N/A Priority: Normal
NCT ID: NCT01370356 Org: User:
Start: 07/31/11 End: 07/31/13 Due: 07/31/14

Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)

Phase: N/A Priority: Normal
NCT ID: NCT01513902 Org: User:
Start: 03/31/13 End: 12/31/15 Due: 12/31/16

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00036140 Org: User:
Start: - End: - Due: -

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

Phase: N/A Priority: Normal
NCT ID: NCT02955160 Org: User:
Start: 11/03/16 End: 08/01/17 Due: 08/01/18